Halozyme Therapeutics, Inc. - stock earnings
HALO Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | 85.4 million USD | 230.0 million USD |
| 2023Q3 | 81.8 million USD | 216.0 million USD |
| 2023Q2 | 74.8 million USD | 221.0 million USD |
| 2023Q1 | 39.6 million USD | 162.1 million USD |
| 2022Q4 | 57.7 million USD | 181.5 million USD |
| 2022Q3 | 61.6 million USD | 209.0 million USD |
| 2022Q2 | 22.7 million USD | 152.4 million USD |
| 2022Q1 | 60.1 million USD | 117.3 million USD |
| 2021Q4 | 66.8 million USD | 102.0 million USD |
| 2021Q3 | 216.6 million USD | 115.8 million USD |
| 2021Q2 | 91.5 million USD | 136.5 million USD |
| 2021Q1 | 27.9 million USD | 89.0 million USD |
| 2020Q4 | 73.2 million USD | 121.7 million USD |
| 2020Q3 | 36.2 million USD | 65.3 million USD |
| 2020Q2 | 25.8 million USD | 55.2 million USD |
| 2020Q1 | -6.1 million USD | 25.4 million USD |
| 2019Q4 | -34.4 million USD | 53.7 million USD |
| 2019Q3 | -25.0 million USD | 46.2 million USD |
| 2019Q2 | -14.6 million USD | 39.1 million USD |
| 2019Q1 | 1.8 million USD | 56.9 million USD |
| 2018Q4 | -2.1 million USD | 60.2 million USD |
| 2018Q3 | -27.9 million USD | 25.6 million USD |
| 2018Q2 | -22.9 million USD | 35.2 million USD |
| 2018Q1 | -27.5 million USD | 30.9 million USD |
| 2017Q4 | 123.9 million USD | 189.6 million USD |
| 2017Q3 | 2.7 million USD | 63.7 million USD |
| 2017Q2 | -30.8 million USD | 33.8 million USD |
| 2017Q1 | -32.9 million USD | 29.6 million USD |
| 2016Q4 | -27.4 million USD | 39.0 million USD |
| 2016Q3 | -28.9 million USD | 31.9 million USD |
| 2016Q2 | -26.9 million USD | 33.3 million USD |
| 2016Q1 | -19.8 million USD | 42.5 million USD |
| 2015Q4 | 4.3 million USD | 52.2 million USD |
| 2015Q3 | -24.5 million USD | 20.8 million USD |
| 2015Q2 | 3.0 million USD | 43.4 million USD |
| 2015Q1 | -15.1 million USD | 18.7 million USD |
| 2014Q4 | -5.3 million USD | 30.4 million USD |
| 2014Q3 | -20.3 million USD | 14.6 million USD |
| 2014Q2 | -16.3 million USD | 18.4 million USD |
| 2014Q1 | -26.5 million USD | 12.0 million USD |
| 2013Q4 | -22.0 million USD | 12.5 million USD |
| 2013Q3 | -19.3 million USD | 16.0 million USD |
| 2013Q2 | -22.9 million USD | 14.5 million USD |
| 2013Q1 | -19.3 million USD | 11.8 million USD |
| 2012Q4 | -4.4 million USD | 21.8 million USD |
| 2012Q3 | -20.0 million USD | 5.3 million USD |
| 2012Q2 | -14.0 million USD | 7.8 million USD |
| 2012Q1 | -15.1 million USD | 7.4 million USD |
| 2011Q4 | -18.4 million USD | 2.4 million USD |
| 2011Q3 | 5.2 million USD | 22.9 million USD |
| 2011Q2 | 3.1 million USD | 23.2 million USD |
| 2011Q1 | -9.6 million USD | 7.5 million USD |
| 2010Q4 | -16.9 million USD | 3.6 million USD |
| 2010Q3 | -12.4 million USD | 3.4 million USD |
| 2010Q2 | -12.2 million USD | 3.2 million USD |
| 2010Q1 | -11.8 million USD | 3.4 million USD |
| 2009Q4 | -12.7 million USD | 6.4 million USD |
| 2009Q3 | -13.9 million USD | 3.0 million USD |
| 2009Q2 | -17.1 million USD | 1.4 million USD |
| 2009Q1 | -14.7 million USD | 2.8 million USD |
| 2008Q4 | -16.8 million USD | 3.1 million USD |
| 2008Q3 | -10.9 million USD | 2.5 million USD |
| 2008Q2 | -11.0 million USD | 1.4 million USD |
| 2008Q1 | -10.0 million USD | 1.8 million USD |
| 2007Q4 | -8.7 million USD | 1.3 million USD |
| 2007Q3 | -7.0 million USD | 942881 USD |
| 2007Q2 | -4.8 million USD | 708516 USD |
| 2007Q1 | -3.4 million USD | 810215 USD |
| 2006Q4 | -4.4 million USD | 426326 USD |
| 2006Q3 | -3.7 million USD | 362477 USD |
| 2006Q2 | -3.2 million USD | 119662 USD |
| 2006Q1 | -3.5 million USD | 73281 USD |
| 2005Q4 | -3.5 million USD | 55862 USD |
| 2005Q3 | -3.7 million USD | 25644 USD |
| 2005Q2 | -2.9 million USD | 45703 USD |
| 2005Q1 | -3.2 million USD | ? USD |
| 2004Q4 | -2.5 million USD | ? USD |
| 2004Q3 | -3.3 million USD | ? USD |
| 2004Q2 | -2.1 million USD | ? USD |
| 2004Q1 | -1.3 million USD | ? USD |
| 2003Q4 | -53918 USD | 2319 USD |
| 2003Q3 | -9462 USD | 12606 USD |
| 2003Q2 | -4849 USD | 7960 USD |
| 2003Q1 | -9874 USD | 2820 USD |
| 2002Q4 | -45941 USD | 34333 USD |
| 2002Q3 | -12610 USD | 16741 USD |
| 2002Q2 | -16074 USD | 7827 USD |
| 2002Q1 | 9362 USD | 28868 USD |
HALO Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 281.6 million USD | 829.3 million USD |
| 2022 | 202.1 million USD | 660.1 million USD |
| 2021 | 402.7 million USD | 443.3 million USD |
| 2020 | 129.1 million USD | 267.6 million USD |
| 2019 | -72.2 million USD | 196.0 million USD |
| 2018 | -80.3 million USD | 151.9 million USD |
| 2017 | 63.0 million USD | 316.6 million USD |
| 2016 | -103.0 million USD | 146.7 million USD |
| 2015 | -32.2 million USD | 135.1 million USD |
| 2014 | -68.4 million USD | 75.3 million USD |
| 2013 | -83.5 million USD | 54.8 million USD |
| 2012 | -53.6 million USD | 42.3 million USD |
| 2011 | -19.8 million USD | 56.1 million USD |
| 2010 | -53.2 million USD | 13.6 million USD |
| 2009 | -58.4 million USD | 13.7 million USD |
| 2008 | -48.7 million USD | 8.8 million USD |
| 2007 | -23.9 million USD | 3.8 million USD |
| 2006 | -14.8 million USD | 981746 USD |
| 2005 | -13.3 million USD | 127209 USD |
| 2004 | -9.1 million USD | ? USD |
| 2003 | -79091 USD | 25705 USD |
| 2002 | -65263 USD | 87769 USD |
| 2001 | -39652 USD | 24685 USD |
HALO
Price: $39.30
52 week price:
Earnings Per Share: 2.10 USD
P/E Ratio: 18.88
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 402302
Ebitda: 127.5 millionMarket Capitalization: 5.1 billion